Waters Corp. Q3 Adjusted EPS Rises 21%; Raises Annual Outlook; Stock Up
Waters Corp. (WAT) reported Q3 net income fell to $81M ($0.82 EPS) due to costs, but adjusted EPS rose 21% to $4.10. Revenue hit $1.767B, with organic growth of 9%. The company raised its 2026 outlook, expecting organic revenue growth of 9.1% to 9.7% and adjusted EPS of $14.60 to $14.70. Shares rose 6% in pre-market trading.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise suggest stronger demand for the company's biosciences and diagnostic solutions businesses.
Market read
Earnings beat and raised outlook are likely to drive short‑term buying in WAT and may influence related sector stocks.
What to watch
Potential integration risks from recent acquisitions could temper long‑term upside.
Background
Waters Corp, a provider of analytical instruments, released its Q3 results and updated full‑year guidance.
Ticker impact
Waters Corp reported Q3 adjusted EPS up 21% YoY and raised full-year outlook, sending shares up ~6% pre‑market.
upward pressure as investors price in higher revenue and EPS guidance
The company posted stronger-than-expected adjusted earnings and lifted its full‑year revenue and EPS forecasts, which historically supports a short‑term rally.
Market effects
Positive for analytical instruments and life‑science services sector, may lift peers.
U.S. market participants may see a modest boost in biotech/diagnostics exposure.
Limited to investors tracking US‑listed life‑science equipment makers.
Counterpoint
If the raised guidance already priced in, the stock could face short‑term profit‑taking.
Key entities
- ExecutiveUdit Batra
President & CEO of Waters Corp, quoted on the outlook.
